Patent Watch: Avecho Targets Oral Cannabinoid Delivery
Avecho’s application describes an oral cannabinoid formulation combining tocopheryl phosphates with long-chain triglycerides or long-chain fatty acids. Cannabinoids are the intended active pharmaceutical ingredients, while the accompanying compounds…
Patent Watch: Cryogenic Cannabinoid Nanoparticles
The application claims a process for producing cannabinoid nanoparticles under cryogenic conditions and incorporating them into beverage compositions. Cannabinoids serve as the active ingredients, while nanoparticle engineering and the beverage matrix…
“NordicCan A/S Develops Innovative Cannabinoid Lozenges”
NordicCan A/S has filed a patent application for a cannabinoid lozenge formulation, which may offer enhanced bioavailability and targeted delivery of cannabinoids. The claimed invention involves a specific combination of excipients and APIs to create a…
Curaleaf Laboratories becomes first UK manufacturer of medical cannabis suppositories
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchIndustryDosingSafety Why This Matters The availability of cannabis suppositories represents a clinically…
ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice … – Lincoln Journal
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchIndustryCBD Why This Matters This patent protection for surface acoustic wave ultrasound combined with…
Can Mouth-Dissolving Films and Gels Solve Cannabis Medicine’s Bioavailability Problem?
Oral mucosal cannabinoid bioavailability offers a promising alternative to traditional oral ingestion by bypassing first-pass metabolism. Films and gels designed for transmucosal absorption can enhance cannabinoid delivery. This review examines the…
CBD in Vaporised Cannabis Boosts THC Levels in the Blood, Study Finds
The study on cbd thc interaction vaporised cannabis shows significantly higher THC blood levels when CBD is co-inhaled with THC. This finding challenges previous assumptions about CBD's neutrality in cannabis products. Understanding this interaction is…
CBD in Vaporised Cannabis Raises THC Blood Levels, Study Finds—but Age Differences Remain Unclear
A randomized crossover trial found that CBD THC vaporised cannabis interaction significantly raises THC blood levels compared to THC alone. This challenges previous assumptions about cannabinoid pharmacokinetics with inhaled cannabis. The study…
Can Oral Mucosal Delivery Unlock Cannabinoid Medicine’s Potential?
Oral mucosal cannabinoid absorption offers a promising alternative to traditional oral ingestion by bypassing hepatic metabolism. This method enhances bioavailability and may improve therapeutic consistency. Understanding these delivery systems is…
How CBD Affects THC Levels in Vaporised Cannabis: New Pharmacokinetic Insights
This study investigates CBD THC interaction pharmacokinetics in vaporised cannabis, revealing that CBD raises THC blood levels. The findings challenge assumptions about CBD's mitigating effects on THC. These results have important implications for…
